FDA clears Dexcom Stelo as the first OTC CGM for children, raising new questions around app access, caregiver oversight, school device rules, and reimbursement.
In March 2024, the FDA approved the first over-the-counter continuous glucose monitors (CGMs), marking a quiet but significant shift in how we can track and understand our health. Devices like ...
SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter ...
Over-the-counter continuous glucose monitors have moved from a diabetes-only tool into the broader metabolic health conversation, and shoppers now face a real decision. Here is an OTC CGM comparison ...
The U.S. Food and Drug Administration cleared the Stelo system as the first over-the-counter continuous glucose monitor for kids The device is designed for users age 2 and older who do not require ...
The FDA cleared the first over-the-counter (OTC) integrated continuous glucose monitor (CGM) for children 2 years and older with or without diabetes, the agency announced on Friday. The Stelo Glucose ...
The U.S. Food and Drug Administration (FDA) has cleared the first over-the-counter wearable device to track blood sugar in young children. The continuous glucose monitor (CGM)—called the Stelo Glucose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results